NDC 70771-1552 – Febuxostat

Febuxostat 40 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC70771-1552

Product details

Brand name
Febuxostat
Generic name
Febuxostat
Labeler
Zydus Lifesciences Limited
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA205443
Marketed since
March 31, 2023
Listing expires
December 31, 2026
Pharmacologic class
Xanthine Oxidase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Febuxostat →

Package NDC codes (6)

Package NDCDescriptionSince
70771-1552-01000 TABLET in 1 BOTTLE (70771-1552-0)Mar 31, 2023
70771-1552-1100 TABLET in 1 BOTTLE (70771-1552-1)Mar 31, 2023
70771-1552-330 TABLET in 1 BOTTLE (70771-1552-3)Mar 31, 2023
70771-1552-410 BLISTER PACK in 1 CARTON (70771-1552-4) / 10 TABLET in 1 BLISTER PACKMar 31, 2023
70771-1552-5500 TABLET in 1 BOTTLE (70771-1552-5)Mar 31, 2023
70771-1552-990 TABLET in 1 BOTTLE (70771-1552-9)Mar 31, 2023

Other Febuxostat products